Bioiberica has registered for the F3 Krill Replacement Challenge with Palbio, a porcine intestinal mucosa hydrolysate that is highly digestible and a palatable source of protein.
“Our ingredient is a product obtained from the heparin manufacturing process, where the porcine intestinal mucosa is enzymatically hydrolyzed with our proprietary technology Enzyneer®. After hydrolysis, heparin is extracted from the mucosa stream and the remnant liquid product is extraordinarily rich in free amino acids and bioactive peptides. The rest of the manufacturing process consists of concentration and drying with different methods to finally obtain a powder product,” Victor Beneito, director animal nutrition at Bioiberica, explained.
“Our approach to life is based on a sense of respect and protection. Our commitment to sustainability is deeply rooted in the core of our business, based on a circular economy model. We are experts in making the most of each and every one of the raw materials we work with in order to minimize resource waste. During the process of manufacturing our pharmaceutical and nutraceutical products for human and pet health, we also obtain other valuable co-products for feed production and agriculture with high added value. All these production processes are designed to minimize the consumption of water, energy and auxiliary raw materials,” Beneito stated.
Bioiberica has a comprehensive background of field trials and basic research in different terrestrial and marine species, where Palbio has performed consistently over the years showing a positive impact on the intestinal health of young animals.
“We have evaluated Palbio in seabream, shrimp and salmon, replacing fishmeal with soybean meal and including Palbio as a quality protein. The results so far have been positive in terms of performance and health markers allowing producers to optimize costs due to the reduction of fishmeal,” Beneito stated.
“We normally recommend including 3-5% for Palbio 50 and in the case of Palbio 62 at 1-3%. Palbio is used in extrusion and pelletized manufacturing processes without any compromise on attractability and palatability. In fact, Palbio is known for its high palatability and digestibility due to its unique free amino acid profile and especially its high glutamic acid content,” Beneito explained.
“In terms of costs, not only the product is cheaper than krill meal but it also has a positive impact on intestinal health due to its functional properties which eventually lead to better performance,” Beneito explained.
“Krill is an important ingredient but in order to reduce environmental footprint the approach is to look for alternatives that don’t have a negative impact on cost or performance, and in this case, Palbio can be an ideal candidate for that purpose. We consider the F3 Krill Replacement Challenge a great opportunity for aquaculture producers to find alternative ingredients, and we expect a great challenge with other manufacturers that for sure will bring their best solutions, however, we are confident that our product will have positive outcomes,” Beneito concluded.
Aquafeed.com has been interviewing some registrants of the F3 Krill Replacement Challenge. See below.
Entobel: The attraction of insect meal
eniferBio: The power of mycoprotein
JF Nutritech: Could phytonutrients replace krill?
Stratium: Insect protein to replace krill
Symrise Aqua Feed: Land-based byproducts
Protenga: An insect-based palatability enhancer
Nutrition Technologies: A new insect-based approach
Shaivaa Algaetech: A mix of microalgae
Palmatech Product: A palm oil concentrate
dsm-firmenich: A palatable protein ingredient
BCF Life Science: A functional amino acid concept
China-based Jiangsu Fuhai Biotech Co., Ltd.: A soybean peptide
